{"url_path":"/sec/smnr/8-k/2026-06-25/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-25","source_url":"https://www.sec.gov/Archives/edgar/data/1913577/0001193125-26-283007-index.html","accession_number":"0001193125-26-283007","cik":"0001913577","ticker":"SMNR","issuer_name":"Semnur Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1913577/0001193125-26-283007-index.html","primary_entity_key":"0001913577","primary_entity_name":"Semnur Pharmaceuticals, Inc."},"word_count":78,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits.\n\n(d) Exhibits.\n\nExhibit\nNumber\n\nDescription\n\n104\n\nCover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).\n\n \n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nSEMNUR PHARMACEUTICALS, INC.\n\nBy: /s/ Henry Ji\nName: Henry Ji\nTitle: Chief Executive Officer & President\n\nDate: June 25, 2026"}